VetriScience competitors

Zippia score 3.9

Competitor Summary. See how VetriScience compares to its main competitors:

I-Flow Corporation has the most employees (1,100).

Work at VetriScience?

Share your experience

VetriScience vs competitors

Company	Founding date	Zippia score	Headquarters	# of Locations	Revenue	Employees
VetriScience	1972	3.9	Williston, VT	1	$19.0M	375
Standard Process	1929	3.8	Palmyra, WI	5	$4.4M	200
Platinum Performance	1996	4.4	Buellton, CA	1	$28.0M	50
Hiossen	2006	4.1	Fairless Hills, PA	1	$25.0M	429
BG Medical	-	3.9	Deer Park, NY	1	$20.0M	175
Fukuda Denshi USA	1939	3.3	Redmond, WA	1	$1.8M	25
Accentia Biopharmaceuticals Inc	2002	3.9	Tampa, FL	1	$4.1M	50
Snap Diagnostics	1994	4.0	Wheeling, IL	1	$49.0M	125
Ovation Medical	2009	4.1	Agoura Hills, CA	1	$6.5M	34
Geneid Lab	2012	4.4	Montvale, NJ	1	$8.5M	90
AADCO Medical	1985	3.3	Randolph, VT	1	$13.6M	50
I-Flow Corporation	1985	4.4	Irvine, CA	1	$1.6B	1,100
AccuVein	2006	4.3	Medford, NY	1	$27.2M	105
Shofu Dental	-	3.7	San Marcos, CA	1	$5.8M	72
DFine	2004	4.2	San Jose, CA	1	$16.8M	150
Cypress Bioscience	-	3.9	San Diego, CA	1	$32.0M	150
Sempermed USA	1994	3.4	Clearwater, FL	1	$4.0M	20
Entera Health	2011	4.3	Ankeny, IA	1	$5.0M	60

Rate VetriScience's competitiveness in the market.

VetriScience salaries vs competitors

Compare VetriScience salaries vs competitors

Company	Average salary	Hourly salary	Salary score
VetriScience	$47,047	$22.62	-

Compare VetriScience job title salaries vs competitors

Company	Highest salary	Hourly salary
VetriScience	$37,286	$17.93
DFine	$48,284	$23.21
Fukuda Denshi USA	$38,683	$18.60
Ovation Medical	$37,636	$18.09
Accentia Biopharmaceuticals Inc	$37,401	$17.98
Hiossen	$37,336	$17.95
Cypress Bioscience	$37,303	$17.93
Snap Diagnostics	$37,267	$17.92
Geneid Lab	$37,266	$17.92
Standard Process	$37,245	$17.91
BG Medical	$37,235	$17.90
AADCO Medical	$37,191	$17.88
Sempermed USA	$37,167	$17.87
Shofu Dental	$37,116	$17.84
Entera Health	$37,092	$17.83
AccuVein	$36,911	$17.75
I-Flow Corporation	$36,593	$17.59
Platinum Performance	$35,053	$16.85

Do you work at VetriScience?

Is VetriScience able to compete effectively with similar companies?

VetriScience jobs

VetriScience demographics vs competitors

Compare gender at VetriScience vs competitors

Job title	Male	Female
Entera Health	55%	45%
AccuVein	65%	35%
Shofu Dental	75%	25%
VetriScience	-	-

Male

Female

100%

75%

50%

25%

VetriScience

Shofu Dental

AccuVein

Entera Health

25%

50%

75%

100%

Compare race at VetriScience vs competitors

Company	White	Hispanic or Latino	Black or African American	Asian	Unknown	Diversity score
Shofu Dental	56%	21%	16%	4%	3%	6.6
AccuVein	69%	9%	10%	9%	3%	7.1
Entera Health	68%	12%	14%	3%	3%	7.8

VetriScience and similar companies CEOs

CEOBio

Kook Books

I-Flow Corporation

Kook Books is a Chief Executive Officer at I-Flow and is based in Haven, Kansas.

Jay Kranzler

Cypress Bioscience

Jay Kranzler has been a Founder, CEO, Board Member, and Advisor to leading life science companies for over 30 years. He is currently acting as Founder and Chief Executive Officer of Perception Neuroscience, Acting Chief Medical Officer of Pastorus, Board Member of Pastorus, Avenue Pharmaceuticals, and ImmunoBrain Checkpoint, and Advisor to small and large companies in the pharma/ biotech space. After graduating from Yale University School of Medicine with MD and PhD degrees with a focus in psychopharmacology, Dr. Kranzler joined McKinsey & Company where he contributed toward founding the Firm’s pharmaceutical practice. In 1989, he became the Chief Executive Officer of Cytel Corporation, a company focused on the development of immunomodulatory drugs. He took Cytel public, and negotiated partnerships with both global and Japanese pharmaceutical companies that set new standards for deal size and structure. After Cytel, Dr. Kranzler became Chief Executive Officer of Cypress Bioscience (formerly IMRE Corporation) where he was credited for the development of Savella™ (milnacipran) for the treatment of fibromyalgia, and Karuna Pharmaceuticals, focusing on the treatment of Schizophrenia.

Gregory Barrett (Greg)

DFine

Greg Barrett has more than 35 years of medical device experience. Most recently, Greg was the Chairman, President and CEO of BARRX Medical, where he guided the company to a successful sale to a strategic partner. Prior to joining BARRX, Greg served as President and CEO of ACMI Corporation, Group Executive Vice President at Boston Scientific Corporation, and he has held positions as Vice President, Global Sales and Marketing at both Orthofix Corporation and Baxter Healthcare. He also spent 13 years at C.R. Bard Corporation, where he finished his tenure as Vice President of Marketing in the Cardiosurgery Division. Greg sits on the Board of BaroSense, Inc. and Cutera, Inc. Greg holds a B.A. in Marketing from the University of Texas, Austin.

Robert L. Marchione

Charlie Dubois

Chris Hutchison

Jeff Haines